{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:36Z","timestamp":1788871296805,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofi Pasteur MSD"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.02.070","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T10:22:27Z","timestamp":1425896547000},"page":"2379-2386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad\u00ae) administered concomitantly with a booster dose of a hexavalent vaccine in 12\u201323-month-old infants"],"prefix":"10.1016","volume":"33","author":[{"given":"Klaus A.","family":"Deichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Eymin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.070_bib0145","series-title":"Vaccine schedule","author":"European Centre for Disease Prevention and Control","year":"2014"},{"issue":"RR-04","key":"10.1016\/j.vaccine.2015.02.070_bib0150","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2015.02.070_bib0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1542\/peds.2011-1968","article-title":"Policy statement\u2014prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children","volume":"128","author":"Committee on Infectious Diseases","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0160","series-title":"Table 2: Summary of WHO position papers\u2014recommended routine immunizations for children","author":"World Health Organization","year":"2014"},{"issue":"6","key":"10.1016\/j.vaccine.2015.02.070_bib0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-5","key":"10.1016\/j.vaccine.2015.02.070_bib0170","first-page":"1","article-title":"Combination vaccines for childhood immunization","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Recomm Rep"},{"issue":"19","key":"10.1016\/j.vaccine.2015.02.070_bib0175","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0264-410X(98)00170-4","article-title":"Addressing the challenges to immunization practice with an economic algorithm for vaccine selection","volume":"16","author":"Weniger","year":"1998","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.02.070_bib0180","first-page":"314","article-title":"Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers","volume":"9","author":"Marcy","year":"2003","journal-title":"Am J Manag Care"},{"issue":"11 Suppl","key":"10.1016\/j.vaccine.2015.02.070_bib0185","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","article-title":"Principles of pediatric combination vaccines and practical issues related to use in clinical practice","volume":"20","author":"Decker","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2015.02.070_bib0190","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2015.02.070_bib0195","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2012.08.057","article-title":"Measles, mumps, and rubella virus vaccine (M-M-RII): a review of 32 years of clinical and postmarketing experience","volume":"30","author":"Lievano","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.070_bib0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.2013-4251","article-title":"Impact of vaccination on the epidemiology of varicella: 1995\u20132009","volume":"134","author":"Baxter","year":"2014","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2015.02.070_bib0205","first-page":"e440","article-title":"Impact of MMRV combination vaccine on childhood vaccination compliance","volume":"18","author":"Ackerson","year":"2012","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.vaccine.2015.02.070_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","article-title":"Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria\u2013tetanus\u2013acellular pertussis vaccines","volume":"25","author":"Shinefield","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2015.02.070_bib0215","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jmv.20754","article-title":"The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection","volume":"78","author":"Hammond","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0220","series-title":"Immunological basis for immunization: module 2: diphtheria\u2014update 2009","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0225","series-title":"Immunological basis for immunization: module 3: tetanus\u2014update 2006","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0230","series-title":"Immunological basis for immunization: module 6: poliomyelitis","author":"World Health Organization","year":"1993"},{"issue":"12","key":"10.1016\/j.vaccine.2015.02.070_bib0235","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0240","series-title":"ProQuad: summary of product characteristics","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0245","series-title":"Infanrix hexa: summary of product characteristics","author":"European Medicines Agency","year":"2014"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2015.02.070_bib0250","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.02.070_bib0255","series-title":"Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute","author":"STIKO","year":"2013"},{"issue":"5","key":"10.1016\/j.vaccine.2015.02.070_bib0260","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2011-3198","article-title":"Measles-containing vaccines and febrile seizures in children age 4 to 6 years","volume":"129","author":"Klein","year":"2012","journal-title":"Pediatrics"},{"issue":"34","key":"10.1016\/j.vaccine.2015.02.070_bib0265","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.070_bib0270","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1503\/cmaj.140078","article-title":"Risk of febrile seizures after first dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine: a population-based cohort study","volume":"186","author":"MacDonald","year":"2014","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.vaccine.2015.02.070_bib0275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","article-title":"Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination","volume":"32","author":"Schink","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.070_bib0280","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/INF.0b013e318267fd8b","article-title":"Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin","volume":"31","author":"Ruger","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T11:29:10Z","timestamp":1537788550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":28,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15002704"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad\u00ae) administered concomitantly with a booster dose of a hexavalent vaccine in 12\u201323-month-old infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}